01 March 2021

• Evidence conflicts over efficacy of monoclonal antibodies in severe COVID - CIDRAP
• Development of Monoclonal Antibody Products Targeting SARS-CoV-2, Incl - FDA.gov
• Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19 - FDA.gov
• Chromatography: Monitoring Monoclonal Antibody Breakthrough Curves - AZoM
• Monoclonal antibodies against MERS coronavirus show promise in Phase 1 NIH-sponsored trial - National Institutes of Health